Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US28176E1082
Ticker EW
Company EDWARDS LIFESCIENCES CORP.
Currency $
Price
Aware Investor Index (AII) 0.0650
Recommendation SELL
P/E 81.02
ROE 13.36 %
Capitalization 32,005,016,000 $
Dividend Yield 0.00 %
P/S 9.32
AII Position 510
P/E Position 684
ROE Position 258
Capitalization Position 253
Dividend Yield Position 595
Sales 3,435,300,000 $
10-Year Average Earnings 395,050,000 $
Shares Outstanding 215,900,000
Equity 2,956,200,000 $
Dividend per Share 0 $
Industry Medical Equipment
Country United States
EDWARDS LIFESCIENCES CORP. Investor Relations Web Site http://ir.edwards.com/







Sales:

YEAR MONTH AMOUNT
2017 12 3,435,300,000.00 $
2016 12 2,963,700,000.00 $
2015 12 2,493,700,000.00 $
2014 12 2,322,900,000.00 $
2013 12 2,045,500,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 583,600,000.00 $
2016 12 569,500,000.00 $
2015 12 494,900,000.00 $
2014 12 811,100,000.00 $
2013 12 389,100,000.00 $
2012 12 291,500,000.00 $
2011 12 236,600,000.00 $
2010 12 216,200,000.00 $
2009 12 229,100,000.00 $
2008 12 128,900,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 2,956,200,000.00 $
2016 12 2,619,000,000.00 $
2015 12 2,503,100,000.00 $
2014 12 2,191,400,000.00 $
2013 12 1,559,200,000.00 $
2012 12 1,479,300,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 215,900,000
2016 12 217,800,000
2015 12 220,300,000
2014 12 108,500,000
2013 12 113,800,000
2012 12 118,300,000

 












Bloomberg News for EDWARDS LIFESCIENCES CORP.:



Google News for EDWARDS LIFESCIENCES CORP.:

ExpertGazette - 15 minutes ago
Analysts Weigh in on Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (NYSE:EW) shares traded 0.3% up during most recent session to reach at the closing price of $148.24. The stock ...
Fairfield Current
Sands Capital Management Buys Sarepta Therapeutics Inc ...
Investment company Sands Capital Management buys Sarepta Therapeutics Inc, Edwards Lifesciences Corp, Abiomed Inc, Galapagos NV, ...
Marea Informative (blog)
Edwards Lifesciences Corp. (EW) CEO Michael Mussallem on Q3 ...
Edwards Lifesciences Corp. (NYSE:EW) Q3 2018 Earnings Conference Call October 23, 2018 5:00 PM ET. Executives. David Erickson - Vice ...
Baseball Daily News
Edwards Lifesciences Corp (EW) Sees Significant Increase in Short ...
Edwards Lifesciences Corp (NYSE:EW) saw a significant growth in short interest in October. As of October 31st, there was short interest ...
GuruFocus.com - 4 hours ago
Greenleaf Trust Sells 1820 Shares of Edwards Lifesciences Corp (EW)
Greenleaf Trust trimmed its holdings in shares of Edwards Lifesciences Corp (NYSE:EW) by 2.9% during the 3rd quarter, according to the ...
Seeking Alpha - 23 Oct 2018
Edwards Lifesciences beats by $0.05, misses on revenue
Edwards Lifesciences (NYSE:EW): Q3 Non-GAAP EPS of $1.07 beats by $0.05; GAAP EPS of $1.06 beats by $0.06. Revenue of $921M ...
Motley Fool
Percentage Price Oscillator is Above the Signal Line on Shares of ...
Watching the numbers for Edwards Lifesciences Corp (EW), we have identified the PPO is presently above the signal line. Traders may be ...
Yahoo Finance
Edwards Lifesciences Corp (EW) VP Sells $99848.00 in Stock
Edwards Lifesciences Corp (NYSE:EW) VP Catherine M. Szyman sold 700 shares of Edwards Lifesciences stock in a transaction that occurred ...
StreetInsider.com
Michael A. Mussallem Sells 32900 Shares of Edwards Lifesciences ...
Edwards Lifesciences Corp (NYSE:EW) CEO Michael A. Mussallem sold 32,900 shares of the company's stock in a transaction dated Monday, ...
Fairfield Current - 1 day ago
Edwards Lifesciences Corp (EW) VP Huimin Wang Sells 33800 ...
Edwards Lifesciences Corp (NYSE:EW) VP Huimin Wang sold 33,800 shares of Edwards Lifesciences stock in a transaction on Tuesday, ...


Back